Outcomes included restored walking indices, reversal of contracture, preservation of muscle mass, and complete structural reattachment confirmed by imaging
She's inclusive and knows about all skin types which isn't always the case
Shuang Wang XW, Yangchao Luo, Ying Liang
www.galahealth.co 5 things no one tells you about GLP-1s 1
In a Mayo Clinic study presented at an annual meeting of the Endocrine Society in July 2025, researchers found that, over 18 months, 40 postmenopausal women who combined the GLP-1 drug tirzepatide (used in Mounjaro and Zepbound) with hormone therapy lost an average of 17 percent of their body weight
More and more evidence is showing that the use of DPP4 Inhibitors and GLP1 Receptor Agonists in combination, is a practice worth changing